{"id":9869,"date":"2026-04-21T17:21:14","date_gmt":"2026-04-21T14:21:14","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9869"},"modified":"2026-04-21T17:21:14","modified_gmt":"2026-04-21T14:21:14","slug":"cto-pci-key-points-jacc-2026","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/cto-pci-key-points-jacc-2026\/","title":{"rendered":"CTO PCI \u2014 Key Points (JACC 2026)"},"content":{"rendered":"
CTO PCI \u2014 Key Points (JACC 2026)<\/div>\n
\u2022 CTO PCI improves symptoms & quality of life vs optimal medical therapy (OMT) and –<\/span><\/div>\n
\u2022 Benefit strongest in:<\/span><\/div>\n
\u2022 Single CTO lesion<\/span><\/div>\n
\u2022 Symptomatic patients<\/span><\/div>\n
Clinical Impact<\/div>\n
\u2022 \u274c No clear reduction in:<\/span><\/div>\n
\u2022 Death<\/span><\/div>\n
\u2022 MI<\/span><\/div>\n
Benefit = symptom relief (not survival)<\/div>\n
Effect seen by 12 months<\/div>\n
Key Evidence<\/div>\n
\u2022 Meta-analysis of:<\/span><\/div>\n
\u2022 EUROCTO + DECISION-CTO\u00a0<\/span><\/div>\n
Success & Safety<\/div>\n
\u2022 Procedural success:<\/span><\/div>\n
\u2022 ~89% \u2192 >92%<\/span><\/div>\n
Guidelines Context<\/div>\n
\u2022 \ud83c\uddfa\ud83c\uddf8 US: Class IIb<\/span><\/div>\n
\u2022 \ud83c\uddea\ud83c\uddfa Europe: Class IIa<\/span><\/div>\n
Limitation:<\/div>\n
\u2022 Complexity + operator dependency<\/span><\/div>\n
<\/div>\n
Practical Takeaway<\/div>\n
CTO PCI = symptom-driven decision<\/div>\n
Consider in:<\/div>\n
\u2022 Refractory angina<\/span><\/div>\n
\u2022 Single CTO<\/span><\/div>\n
\u2022 Experienced operator<\/span><\/div>\n
Source: JACC 2026 \/ TCTMD coverage<\/div>\n
<\/div>\n
Source: JACC 2026 | TCTMD (April 9, 2026)<\/div>\n
<\/div>\n
https:\/\/www.tctmd.com\/news\/cto-pci-reduces-symptoms-improves-quality-life-meta-analysis<\/a><\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

CTO PCI \u2014 Key Points (JACC 2026) \u2022 CTO PCI improves symptoms & quality of life vs optimal medical therapy (OMT) and – \u2022 Benefit strongest in: \u2022 Single CTO lesion \u2022 Symptomatic patients Clinical Impact \u2022 \u274c No clear reduction in: \u2022 Death \u2022 MI Benefit = symptom relief (not survival) Effect seen by […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9869","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9869"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9869\/revisions"}],"predecessor-version":[{"id":9870,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9869\/revisions\/9870"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}